Skip to content
PaperFren

Rising frailty flags one-year death risk

Rapid monthly rises in the electronic frailty index marked older adults twice as likely to die within a year, with high specificity.

Source

Frailty trajectories to identify end of life: a longitudinal population-based study

Stow D, Matthews FE, Hanratty B · BMC medicine · 2018

doi.org/10.1186/s12916-018-1148-xRead the full paper ↗89 citationscc by

What they did

Using English primary-care EHR data, researchers compared monthly eFI trajectories for 13,149 decedents and matched controls (n=26,298) over the year before death or a pseudo-end date.

What they found

Rapidly rising frailty (≈0.01 eFI/month) doubled 12-month death risk vs stable frailty; reweighted, this class (~1.1% of population) predicted 1-year mortality with 99.1% specificity.

The limits

What it doesn't show

That eFI alone should replace clinical judgment, or that intervening on trajectory class improves end-of-life care outcomes.

Key terms

eFI
Electronic Frailty Index from primary-care deficit codes (0–1 scale).
Frailty trajectory
Change in eFI over monthly intervals before death.
Specificity
True-negative rate when using rapidly rising frailty to flag 1-year death.
PPV/NPV
Positive/negative predictive values of the rapid-rise class.
Deficit accumulation
Counting clinical deficits to quantify frailty burden.
End-of-life identification
Recognizing patients who may need palliative planning within a year.

Flashcards

1 / 11

Want these cards to stick?

Save the deck to NoteFren and study it with spaced repetition.

Save these cards to NoteFren— study “Rising frailty flags one-year death risk” with spaced repetition

Quiz yourself

1 / 6

Rapidly rising frailty death risk:

Common questions

How large was the sample?

26,298 people (13,149 cases and controls).

What defined rapidly rising frailty?

About 0.01 eFI rise per month (~0.4 deficits).

How much higher was death risk?

About twice vs stable frailty within 12 months.

How specific was the rapid-rise flag?

99.1% specificity (PPV 19.8%, NPV 93.3%).

More on Diagnostic accuracy